Evidence map›Paper›PMID 33235430›Full record

ReviewClinical ophthalmology (Auckland, N.Z.)2020

Corneal Refractive Surgery in Patients with a History of Herpes Simplex Keratitis: A Narrative Review.

Majid Moshirfar, Dallin C Milner, Preston A Baker, Shannon E McCabe, Yasmyne C Ronquillo, Phillip C Hoopes

Open access · goldAbstract readReview
In one paragraph

Review in Clinical ophthalmology (Auckland, N.Z.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. In vivo CRISPR gene editing in patients with herpetic stromal keratitis.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Post-laser refractive surgery keratitis: A concise narrative review.The Journal of international medical research · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Herpes endotheliitis following laser-assistedTaiwan journal of ophthalmology
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Majid MoshirfarHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0003-1024-6250
Dallin C MilnerUniversity of Colorado School of Medicine, Aurora, CO, USA.
Preston A BakerMcGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.ORCID 0000-0003-0559-9545
Shannon E McCabeHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0002-6339-3628
Yasmyne C RonquilloHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0002-8852-4380
Phillip C HoopesHoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.ORCID 0000-0002-2567-8331
Hoopes Vision · USThe University of Texas Health Science Center at Houston · USUniversity of Colorado Denver · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of herpes simplex keratitis (HSK) in patients following corneal refractive surgery is higher than in the general population, and several case reports of ocular morbidity in HSK infection following corneal refractive surgery have been published. HSK is listed by the American Academy of Ophthalmology as a relative contraindication to corneal refractive surgery, although specifics have not been further elucidated. This review summarizes the current literature regarding reactivation of HSK following corneal refractive surgery and provides a guideline for considering corneal refractive surgery in a patient with a previous history of HSK. Based on the current literature, we recommend that corneal refractive surgery is appropriate for patients with a history of HSK without multiple recurrences who have had no evidence of disease for at least one year. In addition to a thorough history and physical examination, we also recommend these patients begin 400 mg twice daily of oral acyclovir or valacyclovir 500 mg once daily for two weeks prior to surgery and continue this regimen for at least two weeks postoperatively or while on topical steroids.

Indexed as

CMVcytomegalovirusherpes prophylaxisherpetic keratitisHSVLASIKPRKPTKshinglesSMILEvaricella zoster

Identifiers

PMID33235430
PMCPMC7678688
OpenAlexW3102158559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.